Please provide your email address to receive an email when new articles are posted on . Historically marginalized populations may see underdiagnosed rates of inborn errors of immunity. Barriers beyond ...
Inherited diseases of metabolism and immunity have more in common than previously recognized, according to a new study. The findings point to a new set of metabolic genes that are important for the ...
Inborn errors of immunity, historically termed primary immunodeficiency disorders, encompass a diverse group of heritable conditions that compromise innate and adaptive immune function. These ...
Behind every unexplained medical condition is a patient hoping for clarity and understanding. For people with suspected inborn errors of immunity (IEIs), genetic testing can facilitate individually ...
Inherited diseases of metabolism and immunity have more in common than previously recognized, according to a new study published in the journal Science Immunology. The findings point to a new set of ...
Focus on Inborn Errors of Immunity expands access to exome and genome testing for the known 200,000+ patients in the US 1 impacted by these conditions and opens new opportunities for GeneDx and ...
Please provide your email address to receive an email when new articles are posted on . The series included six patients with unresponsive atopic dermatitis. Each patient experienced improvements in ...
The study, titled “Association of IgG4-Related Disease with Human Inborn Errors of Immunity,” involved 18 patients diagnosed with IgG4-RD, all of whom underwent Whole Exome Sequencing (WES) to examine ...
Attendees will see some common applications of cell sorting in a department of immunology. Beginning with an introduction of lymphoproliferative disorders in inborn errors of immunity. 1. How cell ...
Dr Alessandro Borghesi’s research, currently conducted across Italy and Switzerland, focuses on identifying monogenic conditions — or their autoimmune phenocopies — that may lead to immune ...
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the commercial expansion into Inborn Errors of ...